[HTML][HTML] Burden of pediatric hepatitis C
MH El-Shabrawi, NM Kamal - World Journal of Gastroenterology …, 2013 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) is a major health burden infecting 170-210 million people
worldwide. Additional 3-4 millions are newly-infected annually. Prevalence of pediatric …
worldwide. Additional 3-4 millions are newly-infected annually. Prevalence of pediatric …
Assessing hepatitis C spontaneous clearance and understanding associated factors—a systematic review and meta‐analysis
DN Aisyah, L Shallcross, AJ Hully… - Journal of viral …, 2018 - Wiley Online Library
New advances in the treatment of hepatitis C provide high levels of sustained viral response
but their expense limits availability in publicly funded health systems. The aim of this review …
but their expense limits availability in publicly funded health systems. The aim of this review …
HCV genotypes and their determinative role in hepatitis C treatment
Nowadays, exposure to infectious diseases caused by pathogenic viruses has become one
of the major human concerns in health fields. In the meantime, hepatitis viruses are …
of the major human concerns in health fields. In the meantime, hepatitis viruses are …
Investigations of interferon-lambda for the treatment of cancer
A Stiff, W Carson - Journal of innate immunity, 2015 - karger.com
Abstract Interferon-lambda (IFN-λ), a recently discovered cytokine, overlaps broadly with
type I IFN signaling, producing antiviral, antiproliferative, and proapoptotic responses. In …
type I IFN signaling, producing antiviral, antiproliferative, and proapoptotic responses. In …
Glucocorticoid receptors, brain-derived neurotrophic factor, serotonin and dopamine neurotransmission are associated with interferon-induced depression
M Udina, R Navinés, E Egmond, G Oriolo… - International Journal …, 2016 - academic.oup.com
Background: The role of inflammation in mood disorders has received increased attention.
There is substantial evidence that cytokine therapies, such as interferon alpha (IFN-alpha) …
There is substantial evidence that cytokine therapies, such as interferon alpha (IFN-alpha) …
HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART
V Lara‐Aguilar, C Crespo‐Bermejo… - Journal of Medical …, 2023 - Wiley Online Library
Coinfection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) increases
immune activation, inflammation, and oxidative stress that could lead to premature …
immune activation, inflammation, and oxidative stress that could lead to premature …
Prevalence of HIV, hepatitis B and C infections and an assessment of HCV-genotypes and two IL28B SNPs among people who inject drugs in three regions of Nepal
HT Kinkel, D Karmacharya, J Shakya, S Manandhar… - PLoS …, 2015 - journals.plos.org
As part of a comprehensive health care programme for people who use drugs in Nepal, HIV
and viral hepatitis B and C status—including risk factors, HCV-genotypes and co-infections …
and viral hepatitis B and C status—including risk factors, HCV-genotypes and co-infections …
Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients
Abstract Interleukin-28B (IL-28B) is suspected to be associated with response to treatment
and one of the basic immunological backgrounds in liver transplant candidate (LTC). We …
and one of the basic immunological backgrounds in liver transplant candidate (LTC). We …
[HTML][HTML] Hepatitis C virus infection in the human immunodeficiency virus infected patient
LN Clausen, LF Lundbo, T Benfield - World journal of …, 2014 - ncbi.nlm.nih.gov
Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) share the same
transmission routes; therefore, coinfection is frequent. An estimated 5-10 million individuals …
transmission routes; therefore, coinfection is frequent. An estimated 5-10 million individuals …
The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015
Abstract Background Hepatitis C virus (HCV) requires epidemiological monitoring to
estimate its disease burden and to develop countermeasures. This study aimed to …
estimate its disease burden and to develop countermeasures. This study aimed to …